NCT01397240View on ClinicalTrials.gov

The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients

PHASE4UnknownINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

June 30, 2013

Conditions
Patients Taking Low-dose Aspirin
Interventions
DRUG

Albis Tab

2 Tab, twice a day, 12 weeks

DRUG

Placebo

2 Tab, twice a day, 12 weeks

Trial Locations (1)

Unknown

RECRUITING

Gangnam severance Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY